← All Sponsors
SPONSOR

IDRx Inc. - A GSK Company

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Gastrointestinal NeoplasmsGastrointestinal Stromal Tumor (GIST)Digestive System DiseaseGastrointestinal DiseasesMetastatic Cancer
NCT05489237 Phase 1
Recruiting

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

Gastrointestinal Neoplasms
United States, Belgium, China View Trial →